NPPB and hydrops fetalis: The most significant cardioprotective effects were seen in patients already at a high risk of cardiovascular events and severe HF - noted in EMPEROR-REDUCED by the percentage of ejection fraction and those who had a history in the last 12 months of HF exacerbation and level of N-terminal brain natriuretic peptide (BNP) [20].